A unique vision
As pressure on resources increases, health care companies are seeking new ways to commercialise their therapeutics and gain a competitive advantage.
From small beginnings Commercial Eyes has rapidly grown to become a leading pharmaceutical and medical device commercialisation business. With a team of nearly 100 people, we have assisted more than 650 clients representing the full spectrum of health technology companies.
Commercial Eyes provides a comprehensive commercialisation service delivering expert, individualised advice and support from the early phase of pharmaceutical and medical device development, through the complex systems of registration and reimbursement, meeting marketed product obligations and pharmacovigilance, whilst also developing tailored patient support and medical communication programs.
Why Commercial Eyes sees clearly
Our people
We have the industry’s best and brightest consultants, led by an experienced management team.
Many of our consultants are experienced industry professionals – they know and have experienced the sort of challenges you face on a daily basis.
We work closely with you to provide a solution tailored to your needs.
Our reputation
We have for 19 years delivered high quality, customer-focussed results in the Australian and New Zealand regulated therapeutics and healthcare industry.
We are known for our capabilities and outcomes across the sector and our network spans industries , including pharmaceuticals, medical devices, consumer health products and biotechnology).
Our knowledge
We have leading current insights and a strong understanding of the industry’s future.
Our understanding is based on industry, government, clinical, and community experience.
Our services
Our range of commercialisation and product growth services is unsurpassed.
We are the only professional services company in Australia to offer the combination of strategic commercialisation advice, medicine, medical device and consumer health product registration. market access and pricing services combined with a comprehensive patient engagement and medical communications capability.
Our comprehensive Medical Service has redefined and set a benchmark of how medical information and pharmacovigilance drug safety can be delivered.
Key people
